These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2568931)

  • 1. Interleukin 2 receptor expression and interleukin 2 production in exponentially growing T cells: major differences between in vivo and in vitro proliferating T lymphocytes.
    Rocha B; Lembezat MP; Freitas A; Bandeira A
    Eur J Immunol; 1989 Jun; 19(6):1137-45. PubMed ID: 2568931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
    Davignon JL; Kimoto M; Kindler V; De Kossodo S; Vassalli P; Izui S
    Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "In vivo" activated splenic T cells are refractory to interleukin 2 growth "in vitro".
    Bandeira A; Larsson EL; Forni L; Pereira P; Coutinho A
    Eur J Immunol; 1987 Jul; 17(7):901-8. PubMed ID: 3111860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
    Palacios R
    Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine thymic nurse cell clone supports the growth of fetal thymocytes in the presence of interleukin 2.
    Doi H; Nakagawa S; Nagata K; Hata M; Kasahara S; Sakata T; Suzuki R; Nanno M; Sugamura K; Itoh T
    Eur J Immunol; 1991 Mar; 21(3):783-92. PubMed ID: 1672648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct activation of murine resting T cells by con A or anti-CD3 Ig.
    Quintáns J; Yokoyama A; Evavold B; Hirsch R; Mayforth RD
    J Mol Cell Immunol; 1989; 4(4):225-35; discussion 235-7. PubMed ID: 2532886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte-dependent induction of proliferation of human peripheral T cells by recombinant interleukin 2.
    Roosnek EE; Brouwer MC; Kipp JB; Aarden LA
    Eur J Immunol; 1986 Jan; 16(1):35-40. PubMed ID: 3081354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of autoreactive L3T4+ T cells from double-negative (L3T4-/Ly-2-) Thy-1+ spleen cells of normal mice.
    Reimann J; Bellan A; Conradt P
    Eur J Immunol; 1988 Jul; 18(7):989-99. PubMed ID: 2900151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo.
    Scott DE; Gause WC; Finkelman FD; Steinberg AD
    J Immunol; 1990 Oct; 145(7):2183-8. PubMed ID: 2144547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
    Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.
    De Maria A; Malnati M; Moretta A; Pende D; Bottino C; Casorati G; Cottafava F; Melioli G; Mingari MC; Migone N
    Eur J Immunol; 1987 Dec; 17(12):1815-9. PubMed ID: 2961576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
    Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system.
    Evans R; Duffy TM; Kamdar SJ
    Eur J Immunol; 1991 Aug; 21(8):1815-9. PubMed ID: 1907916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of interleukin 2-dependent and -independent B cell proliferation with monoclonal anti-interleukin 2 receptor antibody.
    Hashimoto N; Nabholz M; MacDonald HR; Zubler RH
    Eur J Immunol; 1986 Mar; 16(3):317-20. PubMed ID: 3082653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.
    Yoshizawa H; Chang AE; Shu S
    J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of interleukin 2 and interleukin 4 by immune CD4-CD8+ and their role in the generation of antigen-specific cytotoxic T cells.
    Horvat B; Loukides JA; Anandan L; Brewer E; Flood PM
    Eur J Immunol; 1991 Aug; 21(8):1863-71. PubMed ID: 1907920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.